Abstract
Biologic drugs, including monoclonal antibodies, vaccines, and recombinant proteins, have revolutionized the treatment of various diseases such as cancer, autoimmune disorders, and infectious diseases. This article explores recent advances in biologic drug production and formulation technologies, focusing on innovations in biomanufacturing processes, formulation strategies, and delivery systems. It highlights the integration of cell culture-based production platforms, improvements in drug stability and bioavailability, and the role of novel excipients in enhancing therapeutic outcomes. Future trends, including personalized biologics and bioprinting, are also discussed. The ongoing advancements in biologic drug development promise to improve therapeutic efficacy and accessibility for patients worldwide.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Dr. John Doe (Author)